"Annoucement of ATL1103 Phase 2 trials with its details and funding is a no brainer. We are 100% sure it will happen sooner than later.
Don't get me wrong I appreciate your enthusiasm - but both the underlined and the bold ae probably the most hype fueled optimistic comments that can be made market wide on any stock.
As I've said many times the sector is unlike any other in relation to timeframes required to achieve objectives & sector comparisons for all the goals are highly encouraged to apply time frames as opposed to your own "gut feel" & wishes.
As for those thinking due dilligence by the other party is a smack bang quick to wrap up deal you will also find that pretty much any similar agreement should it be a significant move has due dilligence & company communications by/with that often stretches along way past 12 months before signatures are formalised - on the the upside though atleast exclusivity hasn't been granted.
But hey this time could always be different.... lol
It's all patience in this field not quick returns & rapid fire progress as many seem to forsee.
- Forums
- ASX - By Stock
- anticipated announcements - q1 2012
PER
percheron therapeutics limited
Add to My Watchlist
5.88%
!
0.8¢

"Annoucement of ATL1103 Phase 2 trials with its details and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $2.01K | 251.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1969872 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4817091 | 0.008 |
3 | 2142857 | 0.007 |
2 | 1450000 | 0.006 |
2 | 3999997 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1969872 | 4 |
0.010 | 1993383 | 7 |
0.011 | 2542858 | 6 |
0.012 | 2658324 | 5 |
0.013 | 500000 | 2 |
Last trade - 15.47pm 04/07/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online